SCHEMBL6443570

SCHEMBL6443570

CCc1c2nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)cnc3OCCCO)[nH]c(=O)c2nn1CC

nearest known ligand 0.77

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 20/20 0.77
PDE6C P51160 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6443212 0.94 PDE5A (0.85) PDE5APDE6C
SCHEMBL6444754 0.93 PDE5A (0.87) PDE5APDE6C
SCHEMBL6447389 0.92 PDE5A (0.91) PDE5APDE6C
SCHEMBL13500475 0.91 PDE5A (0.85) PDE5APDE6C
SCHEMBL3586184 0.89 PDE5A (0.84) PDE5APDE6C
SCHEMBL6446212 0.88 PDE5A (0.86) PDE5A
SCHEMBL3583701 0.87 PDE5A (0.93) PDE5APDE6C
SCHEMBL3576608 0.87 PDE5A (1.00) PDE5APDE6C
SCHEMBL3584023 0.86 PDE5A (1.00) PDE5APDE6C
SCHEMBL3586558 0.86 PDE5A (0.80) PDE5APDE6C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1371647-B1 Pyridine-3-carboxylic acid derivatives and their use as intermediates PFIZER (US) 2005-07-13 EP disclosed
EP-1371647-A2 Pyridine-3-carboxylic acid derivatives and their use as intermediates PFIZER INC. (US) 2003-12-17 EP disclosed
EP-1073658-B1 PYRAZOLOPYRIMIDINONE CGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER (US) 2003-08-13 EP disclosed
US-6458951-B2 FOR TREATMENT OF MALE ERECTILE DYSFUNCTION, FEMALE SEXUAL DYSFUNCTION PFIZER INC 2002-10-01 US disclosed
US-6251904-B1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER INC. 2001-06-26 US disclosed